Back to News
Market Impact: 0.5

Sensex, Nifty Open Higher; IT Stocks Surge As Fed Cuts Interest Rates

INFYSMFGNDAQ
Emerging MarketsMarket Technicals & FlowsMonetary PolicyInterest Rates & YieldsCompany FundamentalsM&A & RestructuringInsider TransactionsTechnology & Innovation
Sensex, Nifty Open Higher; IT Stocks Surge As Fed Cuts Interest Rates

Indian equities extended gains for a third consecutive session, with the Sensex rising 0.4% and the Nifty up 0.3% in early trade, fueled by optimism surrounding U.S.-India trade talks and the U.S. Federal Reserve's 25 basis point rate cut to 4.00-4.25%, alongside signals for two more cuts in 2025. This macro development particularly buoyed IT stocks, including Infosys (+1.7%) and HCL Technologies (+1.3%). Notable individual movers included Poonwalla Fincorp (+10%) on a promoter share allotment, Dixon Technologies (+1%) following a significant acquisition, and Biocon (+1.6%) after its subsidiary received FDA approvals, while Yes Bank saw a marginal decline as major shareholders offloaded stakes.

Analysis

Indian equities are exhibiting sustained positive momentum, with the BSE Sensex rising 0.4% and the NSE Nifty gaining 0.3% to mark a third consecutive session of gains. This rally is primarily fueled by two key macroeconomic factors: optimism surrounding ongoing U.S.-India trade negotiations and a dovish pivot from the U.S. Federal Reserve, which cut its benchmark rate by 25 basis points and signaled two further reductions in 2025. This monetary policy shift has directly benefited rate-sensitive IT stocks, as evidenced by the notable gains in Infosys (+1.7%) and HCL Technologies (+1.3%). Beyond the macro tailwinds, the market's advance is supported by a series of positive company-specific catalysts. Poonwalla Fincorp soared 10% on a promoter share allotment, signaling strong insider confidence. Strategic M&A activity is also a driver, with Dixon Technologies rising 1% after announcing a 51% stake acquisition. Furthermore, regulatory success boosted Biocon by 1.6% following FDA approvals for its subsidiary. In contrast, Yes Bank traded marginally lower after major shareholders Bandhan Bank and SBI divested their stakes to Japan's SMBC, marking a significant change in the bank's ownership structure.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.